Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Jeffrey Olson

Concepts (319)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Vitreous Body
14
2020
108
2.920
 Why?
Ophthalmologic Surgical Procedures
5
2017
57
2.160
 Why?
Angiogenesis Inhibitors
11
2022
220
1.980
 Why?
Retina
11
2016
279
1.710
 Why?
Glaucoma
4
2017
219
1.590
 Why?
Eye Foreign Bodies
5
2016
23
1.570
 Why?
Alloys
4
2013
33
1.570
 Why?
Macular Edema
4
2022
42
1.520
 Why?
Retinal Detachment
6
2019
56
1.500
 Why?
Vitrectomy
7
2019
65
1.450
 Why?
Diabetic Retinopathy
6
2019
176
1.420
 Why?
Glaucoma Drainage Implants
3
2016
46
1.390
 Why?
Retinal Diseases
5
2017
88
1.220
 Why?
Intraocular Pressure
7
2017
297
1.210
 Why?
Nanopores
2
2020
7
1.190
 Why?
Intravitreal Injections
7
2022
56
1.160
 Why?
Membranes, Artificial
2
2020
70
1.150
 Why?
Nanotechnology
2
2020
122
1.090
 Why?
Suction
3
2015
32
1.000
 Why?
Sutures
3
2015
52
0.960
 Why?
Anterior Eye Segment
2
2017
9
0.940
 Why?
Choroidal Neovascularization
4
2011
55
0.930
 Why?
Swine
10
2017
760
0.920
 Why?
Suture Techniques
3
2015
118
0.920
 Why?
Equipment Design
6
2017
513
0.890
 Why?
Lens Implantation, Intraocular
2
2015
59
0.870
 Why?
Retinitis
1
2022
19
0.790
 Why?
Retinal Vasculitis
1
2022
10
0.790
 Why?
Aneurysm
1
2022
30
0.780
 Why?
Vitreoretinopathy, Proliferative
2
2019
12
0.730
 Why?
Antibodies, Monoclonal
6
2020
1367
0.720
 Why?
Vascular Endothelial Growth Factor A
6
2020
530
0.720
 Why?
Durapatite
1
2020
33
0.690
 Why?
Retinal Vessels
2
2015
65
0.690
 Why?
Cytomegalovirus Retinitis
2
2013
18
0.680
 Why?
Isoxazoles
2
2013
55
0.660
 Why?
Complement System Proteins
2
2020
313
0.660
 Why?
Eye Injuries, Penetrating
3
2016
16
0.660
 Why?
Scleral Buckling
3
2012
18
0.660
 Why?
Endophthalmitis
2
2017
28
0.660
 Why?
Immunosuppressive Agents
3
2013
853
0.660
 Why?
Disease Models, Animal
8
2020
4063
0.650
 Why?
Stents
2
2013
504
0.610
 Why?
Fluorocarbons
2
2012
109
0.580
 Why?
Anterior Chamber
1
2017
22
0.550
 Why?
Glucocorticoids
2
2020
575
0.550
 Why?
Transducers
1
2017
27
0.550
 Why?
Strabismus
1
2017
28
0.540
 Why?
Sclera
2
2015
36
0.530
 Why?
Filtering Surgery
1
2016
22
0.520
 Why?
Trabeculectomy
1
2017
71
0.510
 Why?
Surgical Instruments
2
2013
50
0.510
 Why?
Fovea Centralis
2
2006
11
0.510
 Why?
Retinal Perforations
2
2005
14
0.500
 Why?
Ocular Hypertension
1
2016
66
0.490
 Why?
Drug Resistance, Multiple, Viral
2
2013
11
0.490
 Why?
Ophthalmology
2
2013
82
0.490
 Why?
Lenses, Intraocular
1
2015
43
0.480
 Why?
Laser Therapy
1
2017
131
0.480
 Why?
Monitoring, Physiologic
1
2017
268
0.480
 Why?
Lasers
1
2015
132
0.470
 Why?
Device Removal
1
2016
136
0.460
 Why?
Prostheses and Implants
1
2016
133
0.460
 Why?
Tomography, Optical Coherence
7
2015
187
0.450
 Why?
Antiviral Agents
2
2013
712
0.450
 Why?
Ischemia
2
2017
406
0.450
 Why?
Fluorescein Angiography
9
2012
143
0.430
 Why?
Models, Cardiovascular
1
2015
191
0.430
 Why?
Rabbits
3
2020
778
0.430
 Why?
Retinal Degeneration
2
2015
37
0.420
 Why?
Artificial Lens Implant Migration
1
2013
3
0.420
 Why?
Animals
18
2020
35360
0.420
 Why?
Choroid
3
2015
62
0.410
 Why?
Macular Degeneration
6
2015
159
0.410
 Why?
Viscosupplements
1
2012
11
0.410
 Why?
Gravitation
1
2012
15
0.410
 Why?
Silicone Oils
1
2012
26
0.400
 Why?
Silicon
1
2012
14
0.400
 Why?
Pupil Disorders
1
2012
5
0.400
 Why?
Eye Enucleation
1
2012
11
0.400
 Why?
Iris
1
2012
19
0.400
 Why?
Viremia
1
2013
131
0.390
 Why?
Quantum Dots
1
2012
36
0.390
 Why?
Silicone Elastomers
1
2012
8
0.390
 Why?
Uveitis, Posterior
1
2012
12
0.390
 Why?
Prosthesis Implantation
1
2013
145
0.390
 Why?
Surgical Stapling
1
2012
13
0.380
 Why?
Fluocinolone Acetonide
1
2012
19
0.380
 Why?
Vitreous Hemorrhage
2
2015
5
0.380
 Why?
Electric Stimulation Therapy
1
2012
76
0.370
 Why?
Cataract Extraction
1
2013
97
0.370
 Why?
Models, Biological
4
2015
1722
0.370
 Why?
Vascular Endothelial Growth Factors
1
2011
78
0.360
 Why?
Materials Testing
1
2012
347
0.340
 Why?
Cytomegalovirus
2
2013
154
0.340
 Why?
Oxygen
1
2015
915
0.330
 Why?
Humans
47
2022
129622
0.320
 Why?
Anti-Inflammatory Agents
1
2012
480
0.300
 Why?
Interleukin 1 Receptor Antagonist Protein
1
2009
252
0.290
 Why?
Biocompatible Materials
1
2012
395
0.290
 Why?
Electroretinography
5
2016
45
0.280
 Why?
von Hippel-Lindau Disease
1
2007
12
0.270
 Why?
Injections
5
2012
174
0.270
 Why?
Pigment Epithelium of Eye
2
2006
34
0.270
 Why?
Puerperal Disorders
1
2007
30
0.270
 Why?
Recombinant Fusion Proteins
4
2022
643
0.260
 Why?
Drug Implants
2
2020
83
0.260
 Why?
Uveal Diseases
1
2006
5
0.260
 Why?
Ocular Hypotension
1
2006
10
0.260
 Why?
Fusobacterium Infections
1
2006
7
0.260
 Why?
Antibodies, Monoclonal, Humanized
6
2015
759
0.260
 Why?
Pharyngeal Diseases
1
2006
15
0.250
 Why?
Needles
2
2017
57
0.250
 Why?
Epiretinal Membrane
1
2005
7
0.250
 Why?
Ciliary Body
1
2006
33
0.250
 Why?
Telangiectasis
1
2005
6
0.250
 Why?
Visual Acuity
7
2019
322
0.250
 Why?
Dementia
2
2022
227
0.240
 Why?
Rats, Inbred BN
3
2011
58
0.240
 Why?
Uveitis
1
2006
127
0.240
 Why?
Receptors, Vascular Endothelial Growth Factor
3
2022
107
0.240
 Why?
Female
26
2022
68770
0.230
 Why?
Kidney Transplantation
2
2013
672
0.230
 Why?
Injections, Intraocular
2
2015
10
0.230
 Why?
Polypropylenes
2
2015
14
0.220
 Why?
Middle Aged
17
2019
31150
0.210
 Why?
Laser Coagulation
3
2012
57
0.200
 Why?
Bevacizumab
6
2015
129
0.200
 Why?
Autoimmune Diseases
1
2006
426
0.200
 Why?
Optic Atrophy
1
2022
10
0.200
 Why?
Hearing Loss, Central
1
2022
5
0.200
 Why?
Retinal Vein Occlusion
2
2015
13
0.190
 Why?
Cell Count
2
2012
314
0.180
 Why?
Rats
4
2012
5499
0.180
 Why?
Dialysis
1
2020
18
0.170
 Why?
Leukemia, Megakaryoblastic, Acute
1
2000
10
0.170
 Why?
Orbital Neoplasms
1
2000
21
0.170
 Why?
Time Factors
4
2017
6556
0.170
 Why?
Adsorption
1
2020
139
0.170
 Why?
Follow-Up Studies
5
2015
4896
0.160
 Why?
Male
21
2019
63674
0.160
 Why?
Adult
11
2022
35572
0.160
 Why?
Biomarkers
2
2020
3973
0.150
 Why?
Wet Macular Degeneration
1
2019
46
0.150
 Why?
Fluorescein-5-isothiocyanate
2
2009
37
0.150
 Why?
Eye Diseases, Hereditary
1
2018
11
0.150
 Why?
Geographic Atrophy
1
2019
69
0.150
 Why?
Miniaturization
2
2015
23
0.150
 Why?
Dextrans
2
2009
82
0.150
 Why?
Iris Diseases
1
2017
6
0.140
 Why?
Choroid Diseases
1
2017
10
0.140
 Why?
Glomerulonephritis, Membranoproliferative
1
1997
13
0.140
 Why?
Enzyme-Linked Immunosorbent Assay
1
2019
833
0.140
 Why?
Dark Adaptation
2
2012
14
0.140
 Why?
Hypertension
1
2006
1242
0.130
 Why?
Antimony
1
2016
5
0.130
 Why?
Infliximab
2
2007
100
0.130
 Why?
Aged, 80 and over
6
2019
7084
0.130
 Why?
Dose-Response Relationship, Drug
3
2014
2012
0.130
 Why?
Polymers
1
2020
479
0.130
 Why?
Pressure
1
2017
237
0.130
 Why?
Sclerostomy
1
2015
4
0.130
 Why?
Foreign-Body Migration
1
2016
35
0.120
 Why?
Treatment Outcome
9
2016
10226
0.120
 Why?
Gyrate Atrophy
1
2015
2
0.120
 Why?
Aged
10
2020
22099
0.120
 Why?
Vitreoretinal Surgery
1
2015
3
0.120
 Why?
Eye Infections, Bacterial
1
2015
27
0.120
 Why?
Diagnostic Techniques, Ophthalmological
1
2015
38
0.120
 Why?
Stress, Mechanical
1
2017
467
0.120
 Why?
Equipment Failure Analysis
1
2015
131
0.120
 Why?
Vitreous Detachment
1
2015
10
0.120
 Why?
Health Knowledge, Attitudes, Practice
2
2014
1279
0.120
 Why?
Partial Pressure
1
2015
29
0.120
 Why?
Hemoglobin SC Disease
1
2015
13
0.120
 Why?
Prosthesis Failure
1
2016
114
0.120
 Why?
Biopsy, Needle
1
2015
189
0.120
 Why?
Feedback
1
2015
162
0.120
 Why?
Oculomotor Muscles
1
2014
38
0.120
 Why?
International Normalized Ratio
1
2014
46
0.110
 Why?
Protein Binding
1
2020
2121
0.110
 Why?
Postoperative Care
1
2015
240
0.110
 Why?
Exchange Transfusion, Whole Blood
1
2013
14
0.110
 Why?
Down Syndrome
1
2000
479
0.110
 Why?
Retinal Artery Occlusion
1
2013
8
0.110
 Why?
Tendons
1
2014
106
0.110
 Why?
In Vitro Techniques
1
2015
1085
0.110
 Why?
Warfarin
1
2014
147
0.110
 Why?
Specific Gravity
1
2012
11
0.100
 Why?
Transducers, Pressure
1
2012
13
0.100
 Why?
Diabetes Mellitus, Type 2
2
2012
2440
0.100
 Why?
Erythrocyte Transfusion
1
2015
181
0.100
 Why?
Research Design
1
2019
1043
0.100
 Why?
Metabolomics
1
2018
652
0.100
 Why?
Adaptation, Ocular
1
2012
4
0.100
 Why?
Rats, Mutant Strains
1
2012
24
0.100
 Why?
Minerals
1
2012
41
0.100
 Why?
Pupil
1
2012
13
0.100
 Why?
Viscosity
1
2012
90
0.100
 Why?
Antineoplastic Agents
2
2020
2061
0.100
 Why?
Corneal Endothelial Cell Loss
1
2012
2
0.100
 Why?
Acetates
1
2012
100
0.100
 Why?
Sodium Chloride
1
2012
138
0.100
 Why?
Endothelium, Corneal
1
2012
16
0.100
 Why?
Retinal Neovascularization
1
2012
25
0.100
 Why?
Tumor Necrosis Factor-alpha
2
2007
1198
0.090
 Why?
Swine, Miniature
1
2012
81
0.090
 Why?
Electrodes, Implanted
1
2012
107
0.090
 Why?
Microsurgery
1
2012
70
0.090
 Why?
Drug Combinations
1
2012
330
0.090
 Why?
Retinal Ganglion Cells
1
2012
97
0.090
 Why?
Adolescent
4
2019
20391
0.090
 Why?
Bruch Membrane
1
2011
6
0.090
 Why?
Gold
1
2012
119
0.090
 Why?
Polyglycolic Acid
1
2011
42
0.090
 Why?
Registries
1
2019
1895
0.090
 Why?
Administration, Oral
1
2013
786
0.090
 Why?
Drug Compounding
1
2011
97
0.090
 Why?
Dissection
1
2011
51
0.090
 Why?
Computer Simulation
1
2015
943
0.090
 Why?
Delayed-Action Preparations
1
2011
173
0.090
 Why?
Models, Animal
1
2012
376
0.080
 Why?
Atrial Fibrillation
1
2014
376
0.080
 Why?
Retrospective Studies
8
2015
14519
0.080
 Why?
Anemia, Sickle Cell
1
2013
254
0.080
 Why?
Lactic Acid
1
2011
303
0.080
 Why?
Cell Survival
1
2012
1086
0.080
 Why?
Bacteria
1
2015
820
0.080
 Why?
Scotoma
1
2008
5
0.070
 Why?
Proliferating Cell Nuclear Antigen
1
2007
52
0.070
 Why?
Optic Neuropathy, Ischemic
1
2007
30
0.070
 Why?
Papilledema
1
2007
39
0.070
 Why?
Severity of Illness Index
2
2014
2742
0.070
 Why?
Pilot Projects
1
2012
1587
0.070
 Why?
Visual Fields
3
2007
87
0.070
 Why?
RNA, Catalytic
1
2007
185
0.070
 Why?
Retinitis Pigmentosa
1
2006
20
0.070
 Why?
Glycogen Storage Disease Type IIb
1
2006
25
0.060
 Why?
Triamcinolone Acetonide
1
2006
27
0.060
 Why?
Fusobacterium necrophorum
1
2006
2
0.060
 Why?
Polyethylene Glycols
1
2011
601
0.060
 Why?
Indocyanine Green
1
2005
19
0.060
 Why?
Vision, Low
3
2013
16
0.060
 Why?
Myopia
1
2006
47
0.060
 Why?
Coloring Agents
1
2005
77
0.060
 Why?
Eye Injuries
1
2006
46
0.060
 Why?
Young Adult
2
2019
12426
0.060
 Why?
Infusions, Intravenous
1
2006
399
0.060
 Why?
Staining and Labeling
1
2005
141
0.060
 Why?
Syndrome
1
2006
341
0.060
 Why?
Cataract
1
2006
208
0.050
 Why?
Multivariate Analysis
2
2019
1502
0.050
 Why?
Diagnosis, Differential
1
2007
1434
0.050
 Why?
Ranibizumab
2
2013
20
0.050
 Why?
Blindness
2
2013
38
0.050
 Why?
Keratitis
1
2000
14
0.040
 Why?
Postoperative Complications
1
2012
2483
0.040
 Why?
Exophthalmos
1
2000
17
0.040
 Why?
Chronic Disease
1
2006
1720
0.040
 Why?
Immunophenotyping
1
2000
311
0.040
 Why?
Tomography, X-Ray Computed
2
2016
2535
0.040
 Why?
Xanthine
1
2018
7
0.040
 Why?
Combined Modality Therapy
2
2013
1206
0.040
 Why?
Electrooculography
1
1997
12
0.040
 Why?
Visual Field Tests
1
1997
16
0.030
 Why?
Color Vision Defects
1
1997
7
0.030
 Why?
Fundus Oculi
1
1997
61
0.030
 Why?
Purines
1
2018
172
0.030
 Why?
Cohort Studies
2
2019
5420
0.030
 Why?
Odds Ratio
1
2019
1023
0.030
 Why?
Photic Stimulation
1
1997
242
0.030
 Why?
Child
2
2015
20882
0.030
 Why?
Vision Disorders
1
1997
135
0.030
 Why?
Microbiological Techniques
1
2015
30
0.030
 Why?
Endotamponade
1
2015
2
0.030
 Why?
Colony Count, Microbial
1
2015
118
0.030
 Why?
Myopia, Degenerative
1
2015
4
0.030
 Why?
Tenon Capsule
1
2014
3
0.030
 Why?
Tissue Adhesions
1
2015
31
0.030
 Why?
Metabolome
1
2018
338
0.030
 Why?
Photography
1
2015
94
0.030
 Why?
Mass Spectrometry
1
2018
716
0.030
 Why?
Atrophy
1
2015
171
0.030
 Why?
Conjunctiva
1
2014
51
0.030
 Why?
Biometry
1
2014
69
0.030
 Why?
Disease Progression
2
2015
2635
0.030
 Why?
Pregnancy
1
2007
6402
0.030
 Why?
Glucose
1
2018
1003
0.030
 Why?
Risk Factors
2
2019
9763
0.030
 Why?
Fatty Acids, Omega-3
1
2014
138
0.020
 Why?
Risk Assessment
2
2014
3240
0.020
 Why?
Retreatment
1
2012
70
0.020
 Why?
Kaplan-Meier Estimate
1
2014
857
0.020
 Why?
Oxidative Stress
1
2018
1269
0.020
 Why?
Global Health
1
2014
329
0.020
 Why?
Survival Analysis
1
2014
1274
0.020
 Why?
Proportional Hazards Models
1
2014
1201
0.020
 Why?
Health Care Costs
1
2014
367
0.020
 Why?
Phenotype
1
2019
3076
0.020
 Why?
Antioxidants
1
2014
559
0.020
 Why?
Anticoagulants
1
2014
636
0.020
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
430
0.020
 Why?
Clinical Trials, Phase II as Topic
1
2009
72
0.020
 Why?
Clinical Trials, Phase I as Topic
1
2009
50
0.020
 Why?
Comorbidity
1
2014
1547
0.020
 Why?
Colorado
1
2019
4420
0.020
 Why?
Prospective Studies
2
2012
7131
0.020
 Why?
Retinal Artery
1
2007
16
0.020
 Why?
Cerebral Angiography
1
2007
109
0.020
 Why?
Lysosomal-Associated Membrane Protein 2
1
2006
28
0.020
 Why?
Infant
1
2000
9025
0.020
 Why?
Frameshift Mutation
1
2006
32
0.020
 Why?
Secondary Prevention
1
2007
218
0.020
 Why?
Prognosis
1
2014
3794
0.020
 Why?
Anti-Bacterial Agents
1
2015
1717
0.010
 Why?
Adrenal Cortex Hormones
1
2008
522
0.010
 Why?
Double-Blind Method
1
2007
1876
0.010
 Why?
RNA, Messenger
1
2007
2708
0.010
 Why?
Aging
1
2008
1776
0.010
 Why?
Olson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (319) concept(s)
_
Co-Authors Expand Description
See all (23) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)